Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-21

Clinical Trial Update: Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial of Vein of Marshall ethanol infusion for persistent atrial fibrillation completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vein of Marshall ethanol infusion (ethanol infusion into vein of Marshall)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Ventricular Tachycardia, Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2025-08-21